On Tuesday, Aptevo Therapeutics Inc (NASDAQ: APVO) opened lower -7.46% from the last session, before settling in for the closing price of $1.34. Price fluctuations for APVO have ranged from $1.04 to $298.00 over the past 52 weeks.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 80.96%. Company’s average yearly earnings per share was noted 99.69% at the time writing. With a float of $16.83 million, this company’s outstanding shares have now reached $16.85 million.
Aptevo Therapeutics Inc (APVO) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Aptevo Therapeutics Inc is 0.10%, while institutional ownership is 7.19%. The most recent insider transaction that took place on Nov 10 ’25, was worth 20,134. In this transaction Director of this company bought 13,513 shares at a rate of $1.49, taking the stock ownership to the 13,514 shares.
Aptevo Therapeutics Inc (APVO) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -178.8 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -155) by -23.8.
According to the Wall Street analysts, stocks earnings will be around 99.69% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 90.39% during the next five years compared to 80.96% growth over the previous five years of trading.
Aptevo Therapeutics Inc (NASDAQ: APVO) Trading Performance Indicators
Check out the current performance indicators for Aptevo Therapeutics Inc (APVO). In the past quarter, the stock posted a quick ratio of 4.03.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -185.07, a number that is poised to hit -0.45 in the next quarter and is forecasted to reach -1.60 in one year’s time.
Technical Analysis of Aptevo Therapeutics Inc (APVO)
Compared to the last year’s volume of 2.27 million, its volume of 0.79 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 60.12%.
During the past 100 days, Aptevo Therapeutics Inc’s (APVO) raw stochastic average was set at 8.85%, which indicates a significant decrease from 52.63% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1003 in the past 14 days, which was lower than the 0.1434 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.4398, while its 200-day Moving Average is $10.4360. Nevertheless, the first resistance level for the watch stands at $1.3300 in the near term. At $1.4200, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.5100. If the price goes on to break the first support level at $1.1500, it is likely to go to the next support level at $1.0600. Should the price break the second support level, the third support level stands at $0.9700.
Aptevo Therapeutics Inc (NASDAQ: APVO) Key Stats
There are currently 16,850K shares outstanding in the company with a market cap of 20.89 million. Presently, the company’s annual sales total 0 K according to its annual income of -24,130 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -7,550 K.
